Jafron Biomedical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 36.63%

Jafron Biomedical Co Ltd (300529) has an Asset Resilience Ratio of 36.63% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 300529 total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥2.03 Billion

≈ $296.72 Million USD Cash + Short-term Investments

Total Assets

CN¥5.54 Billion

≈ $810.11 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Jafron Biomedical Co Ltd's Asset Resilience Ratio has changed over time. See 300529 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jafron Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300529 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.03 Billion	36.63%
Total Liquid Assets	CN¥2.03 Billion	36.63%

Asset Resilience Insights

Very High Liquidity: Jafron Biomedical Co Ltd maintains exceptional liquid asset reserves at 36.63% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Jafron Biomedical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jafron Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Double Medical Technology Inc SHE:002901	Medical Devices	7.79%
Beijing Wandong Medical Technology Co Ltd SHG:600055	Medical Devices	4.92%
Sinocare Inc SHE:300298	Medical Devices	3.53%
MODULIGHT OY EO 1 F:78W	Medical Devices	22.31%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Nova EYE Medical Ltd AU:EYE	Medical Devices	11.08%

Annual Asset Resilience Ratio for Jafron Biomedical Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Jafron Biomedical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.02%	CN¥593.07 Million ≈ $86.79 Million	CN¥5.38 Billion ≈ $787.77 Million	+7.90pp
2021-12-31	3.12%	CN¥150.01 Million ≈ $21.95 Million	CN¥4.81 Billion ≈ $703.87 Million	-4.57pp
2016-12-31	7.69%	CN¥100.00 Million ≈ $14.63 Million	CN¥1.30 Billion ≈ $190.21 Million	--

pp = percentage points

About Jafron Biomedical Co Ltd

SHE:300529 China Medical Devices

Market Cap

$2.23 Billion

CN¥15.21 Billion CNY

Market Cap Rank

#5876 Global

#1245 in China

Share Price

CN¥19.04

Change (1 day)

-0.10%

52-Week Range

CN¥17.31 - CN¥24.54

All Time High

CN¥96.12